SV

Street Verdict

Analyst Scorecard

CLEAN · NSE

Clean Science and Technology Limited

₹690.2

-0.97% (-₹6.75)

Prev. close

₹696.95

Volume

87,380

Delivery %

51.4%

As of

20 Nov 2026

Price history

₹690.2-₹141.7 (-17.03%) · 3M
18 Aug 2026 → 20 Nov 2026
70075080085018 Aug09 Sept06 Oct29 Oct20 Nov
Daily closes · updates after each session

Analyst sentiment

No analyst stances in this range

0 analyst stances · last 90 days · one per analyst

Try a wider range.

Explore by date range →

Analyst opinions

CallAnalystInstrumentVerdictActions
Market commentary · 3 · levels, conditionals, previews, macro & hedged views — context, not graded
CallAnalystInstrumentVerdictActions

Fundamentals

About Clean Science and Technology Limited

Clean Science and Technology Limited, together with its subsidiaries, manufactures fine and specialty chemicals in India, China, the United States, Europe, and internationally. It operates through Performance Chemicals, FMCG Chemicals, and Pharma & Agro Intermediates segments. The company offers performance chemicals, including monomethyl ether of hydroquinone, butylated hydroxy anisole, ascorbyl palmitate, tertiary butyl hydroquinone, hydroquinone, hindered amine light stabilisers, catechol, and butylated hydroxytoluene, as well as clean antiOX 962, 4-oxo tempo, 4-butoxy tempo, clean light stab 770, 4-hydroxy tempo, and dimethyl sebacate. It also provides FMCG chemicals, such as 4-methoxy acetophenone, anisole, guaiacol, butylated hydroxy anisole, l-ascorbyl palmitate, para di-methoxy benzene, and ortho methoxy toluene. In addition, the company offers pharmaceutical and agro intermediates, which includes dicyclohexyl carbodiimide, veratrole, DHDT, para benzoquinone, para di-methoxy benzene, anisole, and ortho methoxy toluene. It serves acrylic monomers and polymers; animal nutrition and feed; coatings, resins, paints, and inks; cosmetic and personal care; electronics and electronic chemicals; edible oils; flavors and fragrances; food and beverages; fuel, lubricants, and industrial fluids; nutraceuticals and dietary supplements; petrochemicals; peptide and fine chemicals synthesis; pharmaceuticals intermediates; plastics; rubber and elastomers; light/UV stabilizers; and water treatment industries. The company was incorporated in 2003 and is headquartered in Pune, India.

Details

Sector

Basic Materials

Industry

Specialty Chemicals

CEO

Mr. Siddharth Ashok Sikchi

Headquarters

Pune

Employees

396

Key stats

Market cap

₹7,067.89 Cr

P/E ratio (TTM)

30.4

Dividend yield

0.91%

EPS (TTM)

₹21.91

Beta (1Y · daily vs NIFTY 50)

0.94

Beta (5Y · monthly vs NIFTY 50)

1.19

Shares float

5.23 Cr

EPS · quarter ended Jun 2026

₹6.90

Upcoming earnings

28 Jan 2027

Financial Performance

01 · Financials

0 Cr250 Cr500 Cr750 Cr1000 Cr₹0%10%20%30%40%FY21FY22FY23FY24FY25FY26
RevenueNet incomeNet income ÷ revenue

EBITDA is omitted from this chart: coverage begins inside the plotted window, and every plotted period must carry a complete point set — the P&L table below has the available figures. Net income ÷ revenue is not drawn for FY21 (revenue was nil or not reported).

02 · Earnings Per Share (EPS)

0102030₹FY22FY23FY24FY25FY26

03 · Dividend Profile

01234₹-10%0%10%20%29 Jul 2210 Feb 2303 Aug 2312 Feb 2429 Aug 2407 Feb 2504 Sept 2506 Feb 2604 Sept 26
Dividend (₹/share)Annualised yieldAnnual dividend growth (FY)

Growth compares completed fiscal-year dividend totals on the company's own calendar: April–March (Indian FY), taken from its reported period-ends. Payout ledger: NSE corporate actions.

04 · Operating Efficiency (Growth Rates)

Balance-sheet-based

-100%0%100%200%FY21FY22FY23FY24FY25FY26
SalesFixed assetsTrade receivablesInventory

05 · Capital Structure & Asset Utilization

0 Cr500 Cr1000 Cr1500 Cr2000 Cr₹0×0.25×0.5×0.75×1×FY21FY22FY23FY24FY25FY26
Total assetsTotal debtDebt / equityAsset turnover

Asset turnover needs a prior year of assets — omitted for the earliest available year.

06 · Asset Base Composition

0 Cr500 Cr1000 Cr1500 Cr2000 Cr₹FY21FY22FY23FY24FY25FY26
Fixed assetsCurrent assetsOther assets

07 · Debt Level & Coverage

-100 Cr0 Cr100 Cr200 Cr₹FY21FY22FY23FY24FY25FY26
DebtFree cash flowCash & equivalents

08 · Profit & Loss

Annual

Line itemFY21FY22FY23FY24FY25FY26
—₹684.89 Cr₹935.80 Cr₹791.49 Cr₹966.64 Cr₹956.55 Cr
EBITDA
—₹329.86 Cr₹431.92 Cr₹373.35 Cr₹426.20 Cr₹387.60 Cr
₹198.00 Cr₹228.50 Cr₹295.18 Cr₹244.03 Cr₹264.41 Cr₹229.66 Cr
Diluted EPS
—₹21.51₹27.78₹22.96₹24.88₹21.6

Revenue, Total expenses (as filed), Employee benefit expense, Other expenses, EBITDA, Tax provision, Interest expense, Other income, Diluted EPS have filed figures for only some of the years shown — the missing years are left blank rather than estimated.

09 · Balance Sheet

Annual

Line itemFY21FY22FY23FY24FY25FY26
₹660.00 Cr₹925.00 Cr₹1,152.00 Cr₹1,396.00 Cr₹1,600.00 Cr₹1,770.00 Cr
₹33.10 L₹33.10 L₹2.06 Cr₹2.03 Cr₹2.13 Cr₹2.14 Cr
Stockholders' equity
₹540.00 Cr₹769.00 Cr₹1,010.00 Cr₹1,204.00 Cr₹1,417.00 Cr₹1,584.00 Cr

Current (short-term) debt, Others have filed figures for only some of the years shown — the missing years are left blank rather than estimated.

Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.

10 · Cash Flow Statement

Annual

Line itemFY21FY22FY23FY24FY25FY26
₹193.00 Cr₹127.00 Cr₹279.00 Cr₹236.00 Cr₹214.00 Cr₹275.00 Cr
Investing cash flow
—₹-78.55 Cr₹-269.82 Cr₹-185.87 Cr₹-151.75 Cr₹-202.51 Cr
—₹-14.70 L₹-55.03 Cr₹-53.19 Cr₹-52.51 Cr₹-63.61 Cr
Capital expenditure
₹-84.00 Cr₹-140.00 Cr₹-183.00 Cr₹-232.00 Cr₹-142.00 Cr₹-201.00 Cr
End cash position
₹9.34 Cr₹57.90 Cr₹12.42 Cr₹10.45 Cr₹20.03 Cr₹28.02 Cr

Change in working capital, Investing cash flow, Financing cash flow, Dividends paid have filed figures for only some of the years shown — the missing years are left blank rather than estimated.

Annual only — the data source has no quarterly cash-flow-statement coverage.

11 · Shareholding Pattern

NSE, quarterly

Line itemSep 21–Jun 22(4Q)Sep 22–Mar 23(3Q)Jun 23Sep 23–Jun 24(4Q)Sep 24–Jun 25(4Q)Sep 25Dec 25Mar 26–Jun 26(2Q)
Promoter78.51%78.50%74.99%74.98%74.97%50.97%50.96%51.29%
Public21.49%21.50%25.01%25.02%25.03%49.03%49.04%48.71%
Employee trusts0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Source: NSE quarterly shareholding-pattern filings, collapsed to periods where the reported percentages held steady — a column spanning several quarters means no change was filed across them. No FII/DII sub-split available from this source — Public includes all non-promoter, non-employee-trust holders.

12 · Peer Comparison

Basic Materials

Company
UltraTech Cement Limited₹3.47 L Cr₹11,81640.64.5310.7%0.31+16.6%-0.0%
JSW Steel Limited₹3.28 L Cr₹1,34311.53.2822.3%1.19+9.3%+13.7%
Asian Paints Limited₹2.32 L Cr₹2,437.848.410.8420.2%0.18+5.1%-3.0%
Hindustan Zinc Limited₹2.31 L Cr₹550.1511.110.2261.1%0.39+18.6%+16.2%
Tata Steel Limited₹2.22 L Cr₹179.9320.12.1810.6%0.90+6.2%+0.4%
Grasim Industries Limited₹2.13 L Cr₹3,13837.82.064.8%2.20+18.2%+8.9%
Hindalco Industries Limited₹2.07 L Cr₹935.812.61.529.8%0.73+15.0%+12.6%
Solar Industries India Limited₹1.76 L Cr₹19,39377.728.0126.7%0.29+30.6%+42.3%
Pidilite Industries Limited₹1.53 L Cr₹1,510.257.014.1222.6%0.04+11.1%+3.8%
Vedanta Aluminium Metal Limited₹1.47 L Cr₹376.8522.2—————
JINDAL STEEL LIMITED₹1.12 L Cr₹1,10539.32.206.6%0.44+5.5%+2.6%
Clean Science and Technology Limited₹7,236.89 Cr₹662.631.14.5714.5%0.00-0.8%-34.3%

Ranked by market cap within Basic Materials, same metrics as the Fundamentals screener. Click a column to sort.

Documents

Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.

CLEAN

Clean Science and Technology's (NSE:CLEAN) Problems Go Beyond Weak Profit

Clean Science and Technology Limited reported a weak profit for the year, with earnings boosted by ₹223 million in unusual items that are unlikely to recur. The company’s earnings per share fell, suggesting its underlying profitability may be lower than the statutory figure. Investors should note the potential impact on future earnings and valuation.

CLEAN

Clean Science targets 55-60% HALS utilisation and capacity

Multibagg AI · 17 days ago